Save an additional 47%!
Black Friday Botox® Training Deals on until November 30. Click here!
Medicare GLP-1 price cuts are making headlines, but two separate programs create confusion for providers. Understanding the 2026 pilot program versus the 2027 price negotiation is essential for accurate patient counseling.
Adding GLP-1 weight loss to your practice is a rewarding way to help your patients and grow your revenue. This guide breaks down the process into four simple, actionable steps.
Discover the secret to building lasting patient trust in weight management by becoming an ally and a guide. This approach transforms the clinical relationship and drives better outcomes
On November 5, 2025, the FDA approved Restylane® Lyft for non-surgical chin augmentation, offering a new option for enhancing the lower face. This article explores the clinical data behind the approval, the principles of facial balancing, and critical patient safety considerations.
An estimated 22 million Americans using GLP-1 medications are now facing a new concern: loose skin on the body after rapid weight loss. This article evaluates Ultherapy PRIME’s recent FDA clearance for non-surgical body contouring, providing practitioners with evidence-based guidance on patient selection, combination therapies, and practice integration strategies.
October 2025 brought major regulatory and clinical updates shaping aesthetic medicine—from the FDA’s RF microneedling alert to new neurotoxin and device approvals. These developments highlight how evidence-based innovation and patient education are redefining safe, inclusive, and profitable practice growth.
October 2025 delivered major breakthroughs in GLP-1 therapy—from tirzepatide’s cardiovascular benefits to the rise of precision obesity medicine. Learn how these findings, along with AI-human coaching and oral GLP-1s, are redefining evidence-based weight management.
September 2025 brought several notable developments in the GLP-1 and weight management space, including new clinical trial data, regulatory guidance changes, and policy updates from the WHO. This monthly update summarizes what clinicians need to know about oral formulations, higher-dose therapies, muscle preservation strategies, and expanding therapeutic applications.
September 2025’s aesthetic medicine update highlights precision neuromodulation, regenerative adjuncts, and brand authenticity. Discover key trends and practical applications to enhance your practice.
Wondering where BOTOX® Cosmetic is actually FDA-approved to treat? This guide covers the four labeled areas, compares Xeomin and Dysport, and explains how to spot and avoid counterfeit toxins for safer, evidence-based care.
November 28-November 30 only!